![Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: A multicenter retrospective study](https://timtailieu.net/upload/document/290492/w126_h160_eribulin-improved-the-overall-survival-from-the-initiation-of-first-line-chemotherapy-for-her2-negative-advanced-breast-cancer-a-multicenter-retrospec-290492.jpg)
Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: A multicenter retrospective study
13
0
0
10 trang